Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1940 1
1941 1
1942 1
1944 2
1945 5
1947 2
1948 1
1949 6
1950 4
1951 3
1952 5
1953 3
1954 1
1955 3
1956 5
1957 2
1958 2
1959 1
1960 1
1961 2
1962 2
1963 2
1964 3
1966 1
1967 2
1968 2
1970 5
1971 1
1981 3
1983 3
1984 3
1986 1
1988 1
1989 1
1991 1
1992 3
1993 4
1998 1
2002 1
2005 1
2014 2
2015 4
2016 7
2017 1
2018 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

107 results
Results by year
Filters applied: . Clear all
Page 1
Adaptive responses to antibody based therapy.
Rodems TS, Iida M, Brand TM, Pearson HE, Orbuch RA, Flanigan BG, Wheeler DL. Rodems TS, et al. Among authors: pearson he. Semin Cell Dev Biol. 2016 Feb;50:153-63. doi: 10.1016/j.semcdb.2016.01.001. Epub 2016 Jan 22. Semin Cell Dev Biol. 2016. PMID: 26808665 Review.
Hemorrhagic herpetic encephalitis.
BUTT EM, PEARSON HE. BUTT EM, et al. Among authors: pearson he. Am J Clin Pathol. 1956 Oct;26(10):1174-9. doi: 10.1093/ajcp/26.10.1174. Am J Clin Pathol. 1956. PMID: 13362174 No abstract available.
MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents.
McDaniel NK, Cummings CT, Iida M, Hülse J, Pearson HE, Vasileiadi E, Parker RE, Orbuch RA, Ondracek OJ, Welke NB, Kang GH, Davies KD, Wang X, Frye SV, Earp HS, Harari PM, Kimple RJ, DeRyckere D, Graham DK, Wheeler DL. McDaniel NK, et al. Among authors: pearson he. Mol Cancer Ther. 2018 Nov;17(11):2297-2308. doi: 10.1158/1535-7163.MCT-17-1239. Epub 2018 Aug 9. Mol Cancer Ther. 2018. PMID: 30093568 Free PMC article.
Correction: AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma.
Brand TM, Iida M, Stein AP, Corrigan KL, Braverman CM, Coan JP, Pearson HE, Bahrar H, Fowler TL, Bednarz BP, Saha S, Yang D, Gill PS, Lingen MW, Saloura V, Villaflor VM, Salgia R, Kimple RJ, Wheeler DL. Brand TM, et al. Among authors: pearson he. Clin Cancer Res. 2018 Dec 1;24(23):6099. doi: 10.1158/1078-0432.CCR-18-3194. Clin Cancer Res. 2018. PMID: 30510088 No abstract available.
Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab.
Iida M, Bahrar H, Brand TM, Pearson HE, Coan JP, Orbuch RA, Flanigan BG, Swick AD, Prabakaran PJ, Lantto J, Horak ID, Kragh M, Salgia R, Kimple RJ, Wheeler DL. Iida M, et al. Among authors: pearson he. Mol Cancer Ther. 2016 Sep;15(9):2175-86. doi: 10.1158/1535-7163.MCT-16-0012. Epub 2016 Jul 15. Mol Cancer Ther. 2016. PMID: 27422810 Free PMC article.
107 results